US 10934274
Quinoline derivatives as TAM RTK inhibitors
granted A61KA61K31/4709A61K31/497
Quick answer
US patent 10934274 (Quinoline derivatives as TAM RTK inhibitors) held by Lead Discovery Center GmbH expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Lead Discovery Center GmbH
- Grant date
- Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/4709, A61K31/497, A61K31/501, A61K31/506